Trial Outcomes & Findings for Bridge Occlusion Balloon in Lead Extraction Procedure (NCT NCT02714153)

NCT ID: NCT02714153

Last Updated: 2021-06-14

Results Overview

After Bridge Balloon deployment and inflation, the degree of blood vessel occlusion will be reported. Measurements will be calculated from fluoroscopic images (using x-ray machine) and venograms (images with injection of contrast agent). Successful balloon occlusion of the superior vena cava (SVC) is defined as \>90% occlusion of the SVC by visual estimate using conventional venography.

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

23 participants

Primary outcome timeframe

33 minutes (average time)

Results posted on

2021-06-14

Participant Flow

Participant milestones

Participant milestones
Measure
Bridge Occlusion Balloon
Bridge Balloon catheter is designed to be used for temporary vessel occlusion of the superior vena cava in applications including perioperative occlusion and emergency control of hemorrhage associated with vascular tears that may occur during lead extraction procedures. Bridge Balloon: The Bridge Balloon will be used in a non-emergent setting to allow for evaluation of how best to integrate this new technology into the investigators clinical practice. The study will focus on the effect of the Bridge balloon on the patient preparation clinical workflow, ease of insertion/positioning/deployment, and the ability to recognize proper inflation and vein sealing under fluoroscopy.
Overall Study
STARTED
23
Overall Study
COMPLETED
22
Overall Study
NOT COMPLETED
1

Reasons for withdrawal

Reasons for withdrawal
Measure
Bridge Occlusion Balloon
Bridge Balloon catheter is designed to be used for temporary vessel occlusion of the superior vena cava in applications including perioperative occlusion and emergency control of hemorrhage associated with vascular tears that may occur during lead extraction procedures. Bridge Balloon: The Bridge Balloon will be used in a non-emergent setting to allow for evaluation of how best to integrate this new technology into the investigators clinical practice. The study will focus on the effect of the Bridge balloon on the patient preparation clinical workflow, ease of insertion/positioning/deployment, and the ability to recognize proper inflation and vein sealing under fluoroscopy.
Overall Study
Death
1

Baseline Characteristics

Bridge Occlusion Balloon in Lead Extraction Procedure

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Bridge Occlusion Balloon
n=23 Participants
Bridge Balloon catheter is designed to be used for temporary vessel occlusion of the superior vena cava in applications including perioperative occlusion and emergency control of hemorrhage associated with vascular tears that may occur during lead extraction procedures. Bridge Balloon: The Bridge Balloon will be used in a non-emergent setting to allow for evaluation of how best to integrate this new technology into the investigators clinical practice. The study will focus on the effect of the Bridge balloon on the patient preparation clinical workflow, ease of insertion/positioning/deployment, and the ability to recognize proper inflation and vein sealing under fluoroscopy.
Age, Continuous
61 years
STANDARD_DEVIATION 15 • n=5 Participants
Sex: Female, Male
Female
4 Participants
n=5 Participants
Sex: Female, Male
Male
19 Participants
n=5 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
n=5 Participants
Race (NIH/OMB)
Asian
0 Participants
n=5 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
n=5 Participants
Race (NIH/OMB)
Black or African American
0 Participants
n=5 Participants
Race (NIH/OMB)
White
23 Participants
n=5 Participants
Race (NIH/OMB)
More than one race
0 Participants
n=5 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants
n=5 Participants
Region of Enrollment
United States
23 participants
n=5 Participants
Comorbidities
Congenital Heart Disease
1 Participants
n=5 Participants
Comorbidities
Diabetes Mellitus
6 Participants
n=5 Participants
Comorbidities
Coronary Artery Disease
11 Participants
n=5 Participants
New York Heart Association Class
I
2 Participants
n=5 Participants
New York Heart Association Class
II
5 Participants
n=5 Participants
New York Heart Association Class
III
13 Participants
n=5 Participants
New York Heart Association Class
IV
3 Participants
n=5 Participants
Ejection Fraction
43 percent
STANDARD_DEVIATION 15 • n=5 Participants
Creatinine
1.05 mg/dL
STANDARD_DEVIATION 0.29 • n=5 Participants

PRIMARY outcome

Timeframe: 33 minutes (average time)

Population: All patients.

After Bridge Balloon deployment and inflation, the degree of blood vessel occlusion will be reported. Measurements will be calculated from fluoroscopic images (using x-ray machine) and venograms (images with injection of contrast agent). Successful balloon occlusion of the superior vena cava (SVC) is defined as \>90% occlusion of the SVC by visual estimate using conventional venography.

Outcome measures

Outcome measures
Measure
Bridge Occlusion Balloon
n=23 Participants
Bridge Balloon catheter is designed to be used for temporary vessel occlusion of the superior vena cava in applications including perioperative occlusion and emergency control of hemorrhage associated with vascular tears that may occur during lead extraction procedures. Bridge Balloon: The Bridge Balloon will be used in a non-emergent setting to allow for evaluation of how best to integrate this new technology into the investigators clinical practice. The study will focus on the effect of the Bridge balloon on the patient preparation clinical workflow, ease of insertion/positioning/deployment, and the ability to recognize proper inflation and vein sealing under fluoroscopy.
Number of Participants With Successful Balloon Occlusion of Superior Vena Cava
First Balloon Deployment
18 Participants
Number of Participants With Successful Balloon Occlusion of Superior Vena Cava
Reposition and Reinflation
5 Participants

SECONDARY outcome

Timeframe: 33 minutes (average time)

Population: All patients.

Time will be calculated in seconds starting from opening the Bridge Balloon Package up to full balloon deployment.

Outcome measures

Outcome measures
Measure
Bridge Occlusion Balloon
n=23 Participants
Bridge Balloon catheter is designed to be used for temporary vessel occlusion of the superior vena cava in applications including perioperative occlusion and emergency control of hemorrhage associated with vascular tears that may occur during lead extraction procedures. Bridge Balloon: The Bridge Balloon will be used in a non-emergent setting to allow for evaluation of how best to integrate this new technology into the investigators clinical practice. The study will focus on the effect of the Bridge balloon on the patient preparation clinical workflow, ease of insertion/positioning/deployment, and the ability to recognize proper inflation and vein sealing under fluoroscopy.
Time of Bridge Balloon Deployment
121 seconds
Standard Deviation 50

SECONDARY outcome

Timeframe: 1 year

Population: All patients.

Heart Rate (in beat per minute) will be collected at 5 points: baseline, after guidewire insertion, at the time of balloon inflation, immediately post deflation and 5 minutes post deflation (all during the procedure itself). This outcome will be reported at the end of the study as if there were any unacceptable or no unacceptable changes in the hemodynamics over the course of the 12 month period.

Outcome measures

Outcome measures
Measure
Bridge Occlusion Balloon
n=23 Participants
Bridge Balloon catheter is designed to be used for temporary vessel occlusion of the superior vena cava in applications including perioperative occlusion and emergency control of hemorrhage associated with vascular tears that may occur during lead extraction procedures. Bridge Balloon: The Bridge Balloon will be used in a non-emergent setting to allow for evaluation of how best to integrate this new technology into the investigators clinical practice. The study will focus on the effect of the Bridge balloon on the patient preparation clinical workflow, ease of insertion/positioning/deployment, and the ability to recognize proper inflation and vein sealing under fluoroscopy.
Number of Participants With Changes in Heart Rate at One Year
Unacceptable Changes
0 Participants
Number of Participants With Changes in Heart Rate at One Year
No Unacceptable Changes
23 Participants

SECONDARY outcome

Timeframe: 1 year

Population: All patients.

Blood pressure in mmHg will be collected at 5 points: baseline, after guidewire insertion, at the time of balloon inflation, immediately post deflation and 5 minutes post deflation (all during the procedure itself). This outcome will be reported at the end of the study as as if there were any unacceptable or no unacceptable changes in the hemodynamics over the course of the 12 month period..

Outcome measures

Outcome measures
Measure
Bridge Occlusion Balloon
n=23 Participants
Bridge Balloon catheter is designed to be used for temporary vessel occlusion of the superior vena cava in applications including perioperative occlusion and emergency control of hemorrhage associated with vascular tears that may occur during lead extraction procedures. Bridge Balloon: The Bridge Balloon will be used in a non-emergent setting to allow for evaluation of how best to integrate this new technology into the investigators clinical practice. The study will focus on the effect of the Bridge balloon on the patient preparation clinical workflow, ease of insertion/positioning/deployment, and the ability to recognize proper inflation and vein sealing under fluoroscopy.
Number of Participants With Changes in Blood Pressure at One Year
Unacceptable Changes
0 Participants
Number of Participants With Changes in Blood Pressure at One Year
No Unacceptable Changes
23 Participants

SECONDARY outcome

Timeframe: 1 year

Population: All patients.

SPO2 will be collected at 5 points: baseline, after guidewire insertion, at the time of balloon inflation, immediately post deflation and 5 minutes post deflation (all during the procedure itself). This outcome will be reported at the end of the study as if there were any unacceptable or no unacceptable changes in the hemodynamics over the course of the 12 month period..

Outcome measures

Outcome measures
Measure
Bridge Occlusion Balloon
n=23 Participants
Bridge Balloon catheter is designed to be used for temporary vessel occlusion of the superior vena cava in applications including perioperative occlusion and emergency control of hemorrhage associated with vascular tears that may occur during lead extraction procedures. Bridge Balloon: The Bridge Balloon will be used in a non-emergent setting to allow for evaluation of how best to integrate this new technology into the investigators clinical practice. The study will focus on the effect of the Bridge balloon on the patient preparation clinical workflow, ease of insertion/positioning/deployment, and the ability to recognize proper inflation and vein sealing under fluoroscopy.
Number of Participants With Changes in SPO2 at One Year
Unacceptable Changes
0 Participants
Number of Participants With Changes in SPO2 at One Year
No Unacceptable Changes
23 Participants

Adverse Events

Bridge Occlusion Balloon

Serious events: 1 serious events
Other events: 0 other events
Deaths: 1 deaths

Serious adverse events

Serious adverse events
Measure
Bridge Occlusion Balloon
n=23 participants at risk
Bridge Balloon catheter is designed to be used for temporary vessel occlusion of the superior vena cava in applications including perioperative occlusion and emergency control of hemorrhage associated with vascular tears that may occur during lead extraction procedures. Bridge Balloon: The Bridge Balloon will be used in a non-emergent setting to allow for evaluation of how best to integrate this new technology into the investigators clinical practice. The study will focus on the effect of the Bridge balloon on the patient preparation clinical workflow, ease of insertion/positioning/deployment, and the ability to recognize proper inflation and vein sealing under fluoroscopy.
Vascular disorders
SVC Tear
4.3%
1/23 • Number of events 1 • 1 year

Other adverse events

Adverse event data not reported

Additional Information

Jude Clancy, MD Associate Professor Term; Director, Lead Management Program

Yale School of Medicine

Phone: (203) 785-4126

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place